GLP-1 receptor agonist use is associated with benefits in a number of different disease and may help treat patients with lupus nephritis.

Target RWE, a leader in real-world evidence solutions in liver disease, presented important research on the use of ...

A SYSTEMATIC review investigating the impact of glucagon-like peptide-1 receptor agonists on alcohol consumption has yielded ...

LANGHORNE, PA — Amplity Health shared valuable findings from its latest study on GLP-1 receptor agonist (GLP-1 RA) usage ...

Other work primarily only included glucagon-like peptide-1 receptor agonists (GLP-1 RAs) among individuals with substance use disorders. We also compared GLP-1 RAs to metformin and ...

Losing weight with anti-obesity medications (AOM) also resulted in decreased alcohol consumption for about half of the ...

Nearly half of individuals consuming alcohol at baseline reduced their alcohol consumption following the initiation of AOMs.

USA: A recent study, published in JAMA Network Open as a research letter, highlights a significant link between anti-obesity ...

Individuals using Ozempic and Wegovy to lose weight are at risk of developing serious health complications if they stop ...

Glucagon-like peptide-1 receptor agonist (GLP-1 RA) use may reduce alcohol consumption and improve outcomes in some individuals.

A study finds that anti-obesity medications may help reduce alcohol consumption, with nearly half of participants in weight ...